Back to index
Granata Bio

Granata Bio

granata.bioBiopharmaceuticals

What AI says about Granata Bio

Granata Bio aims to improve access to fertility treatments by introducing new medications and therapies for reproductive health. With a strong emphasis on clinical development and commercialization, the company seeks to address the barriers faced by patients in the US fertility market.

Is this your brand?

Claim this profile to keep your information accurate and add what's missing.

Products & Services

Fertility Therapeutics

A range of medications and therapies designed to support various stages of assisted reproductive technology (ART), including ovarian stimulation and luteal phase support.

Common Questions

What is Granata Bio's mission?

Granata Bio's mission is to create access for fertility patients by introducing new therapeutic solutions to improve reproductive health.

When was Granata Bio founded?

Granata Bio was founded in 2018.

What barriers does Granata Bio aim to address in fertility treatment?

Granata Bio aims to address the high costs of fertility treatments and the limited insurance coverage available for such services.

What experience does the Granata Bio team have?

The Granata Bio team has over 130 years of combined experience in women's health and reproductive health.

What is the focus of Granata Bio's product development?

Granata Bio focuses on identifying and in-licensing strategic medications used in IVF outside of the US for clinical development and commercialization.

Company Information

Founded
2018
Employees
11-50
Industries
BiopharmaceuticalsWomen's HealthReproductive Health